Intelligence Profile
Science
Mechanism of Action
IGF-1 (mecasermin) is a recombinant human insulin-like growth factor-1 that works by mimicking the natural IGF-1 hormone's cellular and physiological effects. The available evidence provides limited direct mechanistic detail, but several key pathways can be identified from clinical studies.
Growth and Development Pathway
IGF-1 functions as a critical mediator of growth hormone effects, promoting cellular growth and development. Clinical data from the IGFD Registry demonstrates that recombinant IGF-1 (rhIGF-1) treatment can improve height outcomes in patients with severe growth failure, indicating its effectiveness in stimulating linear growth through activation of IGF-1 receptors in target tissues.
Metabolic Effects
One completed clinical trial (NCT01588093) specifically examined "IGF-I Induced Muscle Glucose Uptake," suggesting that IGF-1 enhances glucose metabolism in muscle tissue. This metabolic effect may contribute to its therapeutic benefits but also explains the observed risk of hypoglycemia as a side effect. Registry data indicates that hypoglycemia occurs with predictable frequency in patients receiving rhIGF-1, reflecting the compound's insulin-like metabolic activities.
Neurological Applications
The mechanism in neurological conditions appears related to IGF-1's role in neuronal development and synaptic function. Multiple clinical trials have investigated mecasermin for Rett syndrome (NCT01777542) and 22q13 deletion syndrome (NCT01525901), both neurodevelopmental disorders. A 2024 review suggested IGF-1 has potential as both a diagnostic tool and treatment target for autism spectrum disorders, though the specific neurological mechanisms require further clarification.
Tissue Repair and Protection
Clinical trials have explored IGF-1's potential in cardiac tissue repair following myocardial infarction (NCT01438086) and prevention of bronchopulmonary dysplasia in premature infants (NCT03253263), suggesting broader tissue-protective or regenerative mechanisms beyond growth promotion.
Evidence Limitations
While the clinical applications are diverse, the available evidence provides limited detailed mechanistic data at the molecular level. The therapeutic effects appear to result from IGF-1's fundamental roles in growth signaling, metabolic regulation, and possibly neuroprotection, but more mechanistic research would be needed to fully characterize the pathways involved in each clinical application.
This information is for educational purposes only and should not be considered personalized medical advice. Consult healthcare providers for treatment decisions.